Alba Nicolas-Boluda

Dr. Alba Nicolas-Boluda

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2020 in ACS Nano
Verified
Journal Article
Closed access
ANAlba Nicolas-Boluda
Alba Nicolas-Boluda
JVJavier Vaquero
Javier Vaquero
GLGautier Laurent
Gautier Laurent
GRGilles Renault
Gilles Renault
RBRana Bazzi
Rana Bazzi
FGFlorence Gazeau
Florence Gazeau

1 January 2019 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
MPMax Piffoux
Max Piffoux
ANAlba Nicolas-Boluda
Alba Nicolas-Boluda
Vladimir MULENS-ARIASVladimir MULENS-ARIAS
Vladimir MULENS-ARIAS
SRSophie Richard
Sophie Richard
GRGabriel Rahmi
Gabriel Rahmi
ASAmanda K.A. Silva
Amanda K.A. Silva

1 December 2017 in Pharmacological Research
Verified
Journal Article
Closed access
JKJelena Kolosnjaj-Tabi
Jelena Kolosnjaj-Tabi
IMIris Marangon
Iris Marangon
ANAlba Nicolas-Boluda
Alba Nicolas-Boluda
ASAmanda K.A. Silva
Amanda K.A. Silva
FGFlorence Gazeau
Florence Gazeau

11 October 2018 in Molecules
Verified
Journal Article
Open access
PDF file
Violeta Rodriguez-RuizVioleta Rodriguez-Ruiz
Violeta Rodriguez-Ruiz
JDJose Angel Salatti Dorado
Jose Angel Salatti Dorado
ABAbolfazl Barzegari
Abolfazl Barzegari
ANAlba Nicolas-Boluda
Alba Nicolas-Boluda
AHAmel Houaoui
Amel Houaoui
Graciela Pavon-DjavidGraciela Pavon-Djavid
Graciela Pavon-Djavid
Astaxanthin is a xanthophyll carotenoid showing efficient scavenging ability and represents an interesting candidate in the development of new therapies for preventing and treating oxidative stress-related pathologies. However, its high lipophilicity and thermolability often limits its antioxidant efficacy in human applications. Here, we developed a formulation of lipid carriers to protect astaxanthin’s antioxidant activity. The synthesis of natural astaxanthin-loaded nanostructured lipid carriers using a green process with sunflower oil as liquid lipid is presented. Their antioxidant activity was measured by α-Tocopherol Equivalent Antioxidant Capacity assay and was compared to those of both natural astaxanthin and α-tocopherol. Characterizations by dynamic light scattering, atomic force microscopy, and scattering electron microscopy techniques were carried out and showed spherical and surface negative charged particles with z-average and polydispersity values of ~60 nm and ~0.3, respectively. Astaxanthin loading was also investigated showing an astaxanthin recovery of more than 90% after synthesis of nanostructured lipid carriers. These results demonstrate the capability of the formulation to stabilize astaxanthin molecule and preserve and enhance the antioxidant activity.

16 December 2020 in Nanoscale
Verified
Journal Article
Open access
PDF file
ABArthur Berger
Arthur Berger
IAIrami Araújo-Filho
Irami Araújo-Filho
MPMax Piffoux
Max Piffoux
ANAlba Nicolas-Boluda
Alba Nicolas-Boluda
AGAlice Grangier
Alice Grangier
ASAmanda K. A. Silva
Amanda K. A. Silva
Extracellular vesicles (EVs), especially from stem/stromal cells (SCs), represent a cell-free alternative in regenerative medicine holding promises to promote tissue healing while providing safety and logistic advantages in comparison to cellular counterparts. Herein, we hypothesize that SC EVs, administered locally in a thermoresponsive gel, is a therapeutic strategy for managing post-surgical colo-cutaneous fistulas. This disease is a neglected and challenging condition associated to low remission rates and high refractoriness. Herein, EVs from a murine SC line were produced by a high-yield scalable method in bioreactors. The post-surgical intestinal fistula model was induced via a surgical cecostomy communicating the cecum and the skin in Wistar rats. Animals were treated just after cecostomy with PBS, thermoresponsive Pluronic F-127 hydrogel alone or containing SC EVs. A PET-monitored biodistribution investigation of SC EVs labelled with 89Zr was performed. Fistula external orifice and output assessment, probe-based confocal laser endomicroscopy, MRI and histology were carried out for therapy follow-up. The relevance of percutaneous EV administration embedded in the hydrogel vehicle was indicated by the PET-biodistribution study. Local administration of SC EVs in the hydrogel reduced colo-cutaneous fistula diameter, output, fibrosis and inflammation while increasing the density of neo-vessels when compared to the PBS and gel groups. This multi-modal investigation pointed-out the therapeutic potential of SC EVs administered locally and in a thermoresponsive hydrogel for the management of challenging post-surgical colon fistulas in a minimally-invasive cell-free strategy.

1 January 2018 in Biomaterials
Verified
Journal Article
Closed access
ANAlba Nicolas-Boluda
Alba Nicolas-Boluda
ASAmanda K.A. Silva
Amanda K.A. Silva
SFSylvie FOURNEL
Sylvie FOURNEL
FGFlorence Gazeau
Florence Gazeau